“Sens. Jeanne Shaheen (D-NH), Elizabeth Warren (D-MA) and Rafael Warnock (D-GA) sought more information on supply constraints and whether Novo Nordisk would consider producing Levemir until biosimilars are available.” (Feuerstein's email newsletter)

I wonder if Sen. Shaheen would be interested in taking a look at the FDA. Anybody here from New Hampshire?